Search This Blog

Monday, August 21, 2023

Phathom Submits Data in Support of Erosive GERD New Drug Application

 

  • Six-month stability data remain more than 10x below the acceptable intake limit set by the U.S. Food and Drug Administration (FDA) and continue to support the requested product shelf life

  • Submission of six-month stability data satisfies Phathom's stability data submission requirements for Erosive GERD New Drug Application (NDA) for vonoprazan with a Prescription Drug User Fee Act (PDUFA) goal date of November 17, 2023

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.